| 平消胶囊联合肝动脉栓塞化疗治疗中晚期肝癌60例的临床分析 |
| |
| 引用本文： | 孙秋实,曹传华,张凌云.平消胶囊联合肝动脉栓塞化疗治疗中晚期肝癌60例的临床分析[J].现代肿瘤医学,2012,20(2):322-324. |
| |
| 作者姓名： | 孙秋实 曹传华 张凌云 |
| |
| 作者单位： | 华中科技大学同济医学院附属襄阳医院肿瘤科,湖北,襄阳,441021 |
| |
| 摘 要： | 目的 评价平消胶囊联合介入栓塞化疗治疗中晚期肝癌的临床疗效.方法 选择60例中晚期肝癌患者随机分成两组,治疗组30例用平消胶囊联合肝动脉栓塞化疗术,对照组30例单用介入栓塞化疗术.结果 治疗组和对照组近期有效率分别为66.7%和56.7%,治疗前后生活质量改善率分别为73.3%和53.3%,两组比较有统计学意义(P<0.05).结论 平消胶囊联合肝动脉栓塞化疗术治疗中晚期肝癌可以提高近期有效率,改善生存质量.
|
| 关 键 词： | 平消胶囊 肝动脉栓塞化疗术 中晚期肝癌 |
Clinical evaluation of Pingxiao Capsule combined with TACE in treatment of 60 cases of advanced liver cancer |
| |
| SUN Qiushi,CAO Chuanhua,ZHANG Lingyun.Clinical evaluation of Pingxiao Capsule combined with TACE in treatment of 60 cases of advanced liver cancer[J].Journal of Modern Oncology,2012,20(2):322-324. |
| |
| Authors: | SUN Qiushi CAO Chuanhua ZHANG Lingyun |
| |
| Institution: | Department of Oncology,Xiangyang Hospital of Tongji Medical College,Central China University of Science and Technology,Hubei Xiangyang 441021,China |
| |
| Abstract: | Objective:To evaluate the efficacy of Pingxiao Capsule combinged with TACE for advanced liver cancer.Methods:Sixty patients with advanced liver cancer were divided into two groups.The therapy group(n=30)was treated with Pingxiao Capsule and TACE.The control group was treated with TACE only.Results:The overall effective rate and the life quality improvement rate were 66.7% and 73.3% in therapy group 56.7% and 53.33% in control group respectively.The diference of the two groups was significant(P<0.05).Conclusion:Pingxiao Capsule combinged with TACE for advanced liver cancer could increase the short term effect and improve QOL. |
| |
| Keywords: | Pingxiao Capsule transcatheter arterial chemoembolization advanced liver cancer |
| 本文献已被 CNKI 万方数据 等数据库收录！ |
